Nabriva Therapeutics (NBRVF)
OTHER OTC:NBRVF
US Market
Holding NBRVF?
Track your performance easily

Nabriva Therapeutics (NBRVF) Income Statement

1,019 Followers

Nabriva Therapeutics Income Statement

Last quarter (Q ), Nabriva Therapeutics's total revenue was $2.57M, a decrease of -71.99% from the same quarter last year. In Q, Nabriva Therapeutics's net income was $-12.06M. See Nabriva Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 29.89M$ 36.94M$ 27.22M$ 2.86M$ 9.48M$ 9.66M
Cost of Revenue
$ 47.50M$ 32.90M$ 13.15M$ 766.00K$ 70.00K$ -124.03M
Gross Profit
$ -8.71M$ 4.04M$ 14.07M$ 2.10M$ 9.41M$ 9.66M
Operating Expense
$ 58.51M$ 59.53M$ 77.42M$ 71.15M$ 88.90M$ 124.03M
Operating Income
$ -54.03M$ -55.49M$ -48.53M$ -66.13M$ -79.49M$ -114.38M
Net Non Operating Interest Income Expense
$ -891.00K$ -698.00K$ -901.00K$ -1.65M$ -3.39M$ -84.00K
Other Income Expense
$ -285.00K$ -571.00K$ -469.00K$ 1.57M$ -215.00K$ 272.00K
Pretax Income
$ -54.23M$ -55.62M$ -48.96M$ -69.34M$ -82.66M$ -114.73M
Tax Provision
$ 829.00K$ 1.57M$ 490.00K$ 139.00K$ 101.00K$ 49.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -55.05M$ -57.19M$ -49.45M$ -69.48M$ -82.76M$ -114.78M
Basic EPS
$ -27.39$ -21.32$ -28.50$ -135.25$ -28.00-
Diluted EPS
$ -27.39$ -21.32$ -28.50$ -135.25$ -28.00$ -56.50
Basic Average Shares
$ 11.85M$ 2.68M$ 1.73M$ 513.80K$ 2.97M$ 2.03M
Diluted Average Shares
$ 11.85M$ 2.68M$ 1.73M-$ 2.97M$ 2.03M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 106.01M$ 92.42M$ 90.57M$ 71.92M$ 88.97M$ 124.03M
Net Income From Continuing And Discontinued Operation
$ -55.05M$ -57.19M$ -49.45M$ -69.48M$ -82.76M$ -114.78M
Normalized Income
$ -7.20M-$ -38.68M---
Interest Expense
------
EBIT
$ -53.30M$ -54.92M$ -48.06M$ -67.70M$ -79.02M$ -114.60M
EBITDA
$ -53.19M$ -54.70M$ -47.42M$ -66.88M$ -78.62M$ -114.09M
Currency in USD

Nabriva Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis